RLX Technology

RLXNYSE Cayman Islands Health Care Medicinal Chemicals and Botanical Products

Market cap

$2.102 B

$1.72 +2.38%

Close of 21 Sept 2026

Revenue

$566.1M

#1844 by revenue

Earnings

$131.8M

#1190 by earnings

Shares outstanding

1,548,940,307

Latest filing cover page

P/E ratio

15.9

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#5Regencell BioscienceRGC$2.93B
#6Trulieve CannabisTRLV$2.21B
#7RLX TechnologyRLX$2.10B
#8Cronos GroupCRON$1.23B
#9Glass House BrandsGLAS$698.7M

What if RLX Technology were worth as much as…

Open the what-if tool →

Gold $30.3T

$24,769.03

Per share 14,401× higher

Bitcoin $1.72T

$1,407.07

Per share 818× higher

Nvidia $5.48T

$4,483.40

Per share 2,607× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for RLX Technology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.